Jul 14, 2016 - Eli Lilly (LLY) inked a clinical trial collaboration with Boehringer for the evaluation of abemaciclib-BI 836845 combination for metastatic breast cancer.
Apr 26, 2016 - Eli Lilly & Co. (NYSE:LLY)Q1 2016 Earnings CallApril 26, 2016 9:00 am ETExecutivesJohn C. Lechleiter - Chairman, President & Chief Executive OfficerPhilip Johnson - Vice President, Investor Relations,
Apr 26, 2016 - Earnings Conference Call Start time: April 26, 2016 at 09:00 AM ET.The audio will stream live while the call is active and can be replayed upon its completion.
Sep 22, 2015 - Shire's (SHPG) once-daily, non-stimulant Intuniv received European approval for the treatment of attention deficit hyperactivity disorder in children and adolescents.
Sep 18, 2015 - TG Therapeutics (TGTX) reached an agreement with the FDA related to a Special Protocol Assessment of a phase III study design for TG-1101 for chronic lymphocytic leukemia.
Sep 18, 2015 - 3M Safety and Graphics Business Group, a part of 3M Company (MMM), recently announced a minority equity investment in StrongArm Technologies Inc., - a company that designs innovative safety products.
Sep 18, 2015 - Eli Lilly and Company (LLY) was a big mover last session, as the company saw its shares rise roughly 7% on the day.
Sep 16, 2015 - GW Pharmaceuticals plc (GWPH) announced encouraging top-line data from an exploratory phase IIa study on cannabidiol in patients suffering from schizophrenia who had previously failed to respond adequately to first-line anti-psychotic medications.
Sep 02, 2015 - Amgen (AMGN) inks deal with Novartis for Alzheimer's disease and migraine; reports positive phase III data on romosozumab.
Aug 31, 2015 - Bristol-Myers Squibb Company (BMY) announced that it has entered into a research collaboration and license agreement with QIMR Berghofer Medical Research Institute.